Search

Author/Creator Kpamegan, Eloi

2. A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age. Issue 30 (27th June 2017)

Authors:
August, Allison; Glenn, Gregory M.; Kpamegan, Eloi; Hickman, Somia P.; Jani, Dewal; Lu, Hanxin; Thomas, D. Nigel; Wen, Judy; Piedra, Pedro A.; Fries, Louis F.
Journal:
Vaccine
Issue:
Volume 35:Issue 30(2017)
Page Start:
3749
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice. Issue 16 (7th April 2016)

Authors:
Bengtsson, Karin Lövgren; Song, Haifeng; Stertman, Linda; Liu, Ye; Flyer, David C.; Massare, Michael J.; Xu, Ren-Huan; Zhou, Bin; Lu, Hanxin; Kwilas, Steve A.; Hahn, Timothy J.; Kpamegan, Eloi; Hooper, Jay; Carrion, Ricardo; Glenn, Gregory; Smith, Gale
Journal:
Vaccine
Issue:
Volume 34:Issue 16(2016)
Page Start:
1927
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗